![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2...
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create...
Samsung Biologics breaks ground on Super Plant, the world’s largest and most innovative bio-manufacturing...
Samsung Biologics officially began construction of its Plant 4 in Incheon, South Korea. Dubbed the...
CureVac and WACKER Sign Manufacturing Contract for CureVac’s COVID-19 Vaccine Candidate
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger...
Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
Eli Lilly and Company and Precision BioSciences, Inc. announced a research collaboration and exclusive license...
Exeter University and Medicines Discovery Catapult collaborate on R&D drive
The collaboration will focus on identifying promising innovations that can be adopted through the industry...
Moderna and Pfizer COVID Vaccines: The Comparison
Moderna Inc. on Monday declared that its vaccine was 94.5% effective.
This came just...
COVID-19 Genomics UK Consortium gets £12.2 million funding to expand whole genome sequencing of...
The public will be better protected from COVID-19 with £12.2 million of funding awarded to...
FUJIFILM Cellular Dynamics and Lonza agree to expand the availability and use of induced...
FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem...
Pioneering research potentially reveals early detection of prostate cancer
Pioneering research conducted by University of Virginia in collaboration with Manchester UK based APIS Assay...
Ypsomed collaborates with SCHOTT and Lonza to develop a comprehensive solution for combination products...
Ypsomed advances its patch injector into a comprehensive solution by entering into a collaboration with...